In a randomized, controlled clinical study (Study F), in adult patients with type 2 diabetes not using oral antidiabetic medications (n = 518), a basal-bolus regimen of insulin glargine once daily at bedtime or NPH insulin administered once or twice daily was evaluated for 28 weeks
But the effect is unproven, varies widely, and the medication was not designed to treat drinking
This conclusion by the Mississippi board is based on a board rule that requires that only medications with an FDA indication for weight loss be prescribed to treat weight loss
This legal conflict emerges after the FDA announced that shortages of these medications have ended, thus limiting the compounding of such drugs
Losing weight too fast can also harm bone and muscle health
According to Direct Meds, they work with US-based compounding pharmacies